ATE399176T1 - Nonapeptidische ny-eso-1 derivate und deren verwendung - Google Patents

Nonapeptidische ny-eso-1 derivate und deren verwendung

Info

Publication number
ATE399176T1
ATE399176T1 AT00990987T AT00990987T ATE399176T1 AT E399176 T1 ATE399176 T1 AT E399176T1 AT 00990987 T AT00990987 T AT 00990987T AT 00990987 T AT00990987 T AT 00990987T AT E399176 T1 ATE399176 T1 AT E399176T1
Authority
AT
Austria
Prior art keywords
eso
peptides
nonapeptidiic
derivatives
tetramers
Prior art date
Application number
AT00990987T
Other languages
English (en)
Inventor
Danila Valmori
Jean-Charles Cerottini
Pedro Romero
Vincenzo Cerundolo
Peter Roderick Dunbar
Ji-Li Chen
Original Assignee
Ludwig Inst Cancer Res
Chancellors Masters & Scholars
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/440,621 external-priority patent/US6417165B1/en
Priority claimed from US09/676,005 external-priority patent/US6605711B1/en
Application filed by Ludwig Inst Cancer Res, Chancellors Masters & Scholars filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE399176T1 publication Critical patent/ATE399176T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00990987T 1999-11-15 2000-11-08 Nonapeptidische ny-eso-1 derivate und deren verwendung ATE399176T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/440,621 US6417165B1 (en) 1988-03-27 1999-11-15 NY-ESO-1-peptide derivatives, and uses thereof
US09/514,036 US6689742B1 (en) 2000-02-25 2000-02-25 NY-ESO-1 peptide derivatives, and uses thereof
US09/676,005 US6605711B1 (en) 1999-11-15 2000-09-29 NY-ESO-1 peptide derivatives, and uses thereof

Publications (1)

Publication Number Publication Date
ATE399176T1 true ATE399176T1 (de) 2008-07-15

Family

ID=30771329

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990987T ATE399176T1 (de) 1999-11-15 2000-11-08 Nonapeptidische ny-eso-1 derivate und deren verwendung

Country Status (6)

Country Link
US (2) US6689742B1 (de)
AT (1) ATE399176T1 (de)
DE (1) DE60039306D1 (de)
DK (1) DK1230261T3 (de)
ES (1) ES2309011T3 (de)
PT (1) PT1230261E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794131B1 (en) 1998-01-27 2004-09-21 Ludwig Institute For Cancer Research Lage-1 tumor associated nucleic acids
US8868659B2 (en) * 2001-05-15 2014-10-21 Avaya Inc. Method and apparatus for automatic notification and response
US20050209990A1 (en) * 2004-03-18 2005-09-22 Ordille Joann J Method and apparatus for a publish-subscribe system with access controls
US7734731B2 (en) 2004-03-18 2010-06-08 Avaya Inc. Method and apparatus for a publish-subscribe system with third party subscription delivery
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
SG174877A1 (en) 2009-03-17 2011-11-28 Mdxhealth Sa Improved detection of gene expression
WO2013126402A1 (en) * 2012-02-20 2013-08-29 University Of Virginia Patent Foundation Composition and methods for treating melanoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417165B1 (en) * 1988-03-27 2002-07-09 Ludwig Institute For Cancer Research NY-ESO-1-peptide derivatives, and uses thereof
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
ES2281935T3 (es) * 1997-10-08 2007-10-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Antigeno cancerigeno humano ny eso-1/ca6 y gen que codifica para el mismo.

Also Published As

Publication number Publication date
US6689742B1 (en) 2004-02-10
US20040077548A1 (en) 2004-04-22
ES2309011T3 (es) 2008-12-16
DK1230261T3 (da) 2008-09-22
DE60039306D1 (de) 2008-08-07
PT1230261E (pt) 2008-10-06

Similar Documents

Publication Publication Date Title
CY1122576T1 (el) Ανθρωπινα αντισωματα που δεσμευουν το γονιδιο-3 ενεργοποιησης λεμφοκυτταρων (leg-3), και χρησεις εξ' αυτων
CY1122210T1 (el) Ανθρωπινα αντισωματα anti-sod1
CY1123609T1 (el) Βελτιστοποιηση αντισωματων που δεσμευουν το γονιδιο-3 ενεργοποιησης λεμφοκυτταρων (lag-3), και χρησεις εξ΄ αυτων
CY1107973T1 (el) Σχετιζομενα με ογκους πεπτιδια, που συνδεονται ετεροκλητως με μορια κλασεως ιι αντιγονου ανθρωπινων λευκοκυτταρων
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
EA200501206A1 (ru) Производные от сурвивина пептиды и их применение
BR0315275A (pt) Anticorpos que se ligam a receptor de eritropoietina
TR200001023T2 (tr) Alfa-aril-N-Alkilnitronlar ve onları içeren farmasötik kompozisyonlar.
BRPI0409879A (pt) composições e métodos para imunoterapia especìfica wt1
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
CY1117236T1 (el) Μονοκλωνικα αντισωματα εναντι γλυπικανης-3
IL172854A0 (en) Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
TR201908551T4 (tr) Yakıt bileşimleri.
IL161832A0 (en) Pharmaceutical composition for inducing an immune response in a human or animal
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
TR200100462T2 (tr) Muskarinik agonistleri ve antagonistleri
WO2001036453A3 (en) Ny-eso-1 nanopeptide derivatives, and uses thereof
WO2001004282A3 (en) Replication-competent anti-cancer vectors
ATE399176T1 (de) Nonapeptidische ny-eso-1 derivate und deren verwendung
DE60228609D1 (de) Identifizierung und charakterisierung von genen
ATE325803T1 (de) Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung
ATE363890T1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
EP1601687A4 (de) Verfahren zur erhöhung der ausbreitung von b-zellen
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1230261

Country of ref document: EP